Randal J. Kirk | |
---|---|
Born |
Pleasanton, California, U.S. |
March 1, 1954
Residence | West Palm Beach, Florida, U.S. |
Alma mater |
Radford University (BA, 1976) University of Virginia School of Law (JD, 1979) |
Occupation | Biotech investor; CEO of Intrexon Corporation; founder and senior managing director of Third Security, LLC |
Known for | Biotech investing |
Home town | Dublin, Virginia |
Net worth |
US $ 3.3 billion (est. in January 2017) |
Political party | Independent |
Board member of |
|
Children | 4 |
Randal J. Kirk (born March 1, 1954) is an American businessman and investor in pharmaceuticals and biotechnology. Kirk is the chairman and chief executive officer of Intrexon (NYSE: XON), a biotechnology company. Kirk started as a lawyer, but is best known for his investments in pharmaceutical and biotech companies. In addition to high-profile sales of New River Pharmaceuticals, Inc., and Clinical Data, Inc, Kirk also founded investment firm Third Security, LLC, and has held board seats with biotech companies, such as Scios, Inc., and ZIOPHARM Oncology. He is a billionaire and is listed on the Forbes 400.
Randal J. Kirk was born in Pleasanton, California. The son of an U.S. Air Force master sergeant, Kirk and his family moved from California to Texas before settling in Virginia. Kirk graduated from Dublin High School in Pulaski County, Virginia. Following high school, Kirk worked selling cars and motorcycles, and enrolled part-time at Radford University to study business. He earned a bachelor's degree in Economics at Radford in 1976, followed by a Juris Doctor at the University of Virginia in 1979.
Kirk was admitted to the bar in 1980, becoming the only attorney in Bland, Virginia, and began a practice he ran until 1990. In 1983, he partnered with Bland County pharmacist John Gregory to found the next-day pharmaceutical distributor General Injectables and Vaccines. Kirk and his partners would go on to sell the business to Henry Schein, Inc. for $65 million in 1998.